These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 25169013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [Abstract] [Full Text] [Related]

  • 4. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F, Carrieri C, Galasso R, Scaraggi FA, Di Serio F, Woodhams B, Semeraro N, Colucci M.
    J Thromb Haemost; 2013 Feb; 11(2):315-24. PubMed ID: 23256818
    [Abstract] [Full Text] [Related]

  • 5. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
    Stubblefield WB, Alves NJ, Rondina MT, Kline JA.
    PLoS One; 2016 Feb; 11(2):e0148747. PubMed ID: 26866684
    [Abstract] [Full Text] [Related]

  • 6. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis.
    Stolberg CR, Mundbjerg LH, Funch-Jensen P, Gram B, Juhl CB, Bladbjerg EM.
    Surg Obes Relat Dis; 2018 Jul; 14(7):918-926. PubMed ID: 29706497
    [Abstract] [Full Text] [Related]

  • 7. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
    Bouma BN, Mosnier LO.
    Pathophysiol Haemost Thromb; 2018 Jul; 33(5-6):375-81. PubMed ID: 15692247
    [Abstract] [Full Text] [Related]

  • 8. Plasma fibrin clot properties affect blood loss after surgical aortic valve replacement for aortic stenosis.
    Mazur P, Natorska J, Sobczyk D, Gaweda B, Bartus K, Filip G, Kapelak B, Undas A.
    Eur J Cardiothorac Surg; 2019 Feb 01; 55(2):224-231. PubMed ID: 30063794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
    Leenaerts D, Aernouts J, Van Der Veken P, Sim Y, Lambeir AM, Hendriks D.
    Thromb Haemost; 2017 Jul 26; 117(8):1498-1508. PubMed ID: 28692110
    [Abstract] [Full Text] [Related]

  • 12. Asthma is associated with enhanced thrombin formation and impaired fibrinolysis.
    Bazan-Socha S, Mastalerz L, Cybulska A, Zareba L, Kremers R, Zabczyk M, Pulka G, Iwaniec T, Hemker C, Undas A.
    Clin Exp Allergy; 2016 Jul 26; 46(7):932-44. PubMed ID: 27019085
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P, Zabczyk M, Undas A.
    PLoS One; 2015 Jul 26; 10(4):e0125069. PubMed ID: 25909989
    [Abstract] [Full Text] [Related]

  • 14. Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
    Antovic JP, Antovic A, He S, Tengborn L, Blombäck M.
    Haemophilia; 2002 Nov 26; 8(6):781-6. PubMed ID: 12410647
    [Abstract] [Full Text] [Related]

  • 15. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1998 Nov 26; 80(5):829-35. PubMed ID: 9843179
    [Abstract] [Full Text] [Related]

  • 16. Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?
    Antovic JP, Rafik Hamad R, Antovic A, Blombäck M, Bremme K.
    Thromb Haemost; 2002 Oct 26; 88(4):644-7. PubMed ID: 12362237
    [Abstract] [Full Text] [Related]

  • 17. Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes.
    Bryk AH, Konieczynska M, Rostoff P, Broniatowska E, Hohendorff J, Malecki MT, Undas A.
    Thromb Haemost; 2019 Feb 26; 119(2):213-222. PubMed ID: 30605917
    [Abstract] [Full Text] [Related]

  • 18. Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age.
    Jaworska-Wilczyńska M, Natorska J, Siudut J, Marzec K, Kowalik I, Hryniewiecki T, Undas A.
    Kardiol Pol; 2021 Feb 26; 79(7-8):796-803. PubMed ID: 34002842
    [Abstract] [Full Text] [Related]

  • 19. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H.
    J Endocrinol Invest; 2009 Feb 26; 32(2):169-74. PubMed ID: 19411818
    [Abstract] [Full Text] [Related]

  • 20. Impaired fibrinolysis is associated with the severity of aortic stenosis in humans.
    Natorska J, Wypasek E, Grudzień G, Sadowski J, Undas A.
    J Thromb Haemost; 2013 Apr 26; 11(4):733-40. PubMed ID: 23289423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.